SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-054166
Filing Date
2023-11-02
Accepted
2023-11-02 16:50:13
Documents
2
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1663
2 POA DOCUMENT poa.txt EX-24 3963
  Complete submission text file 0001209191-23-054166.txt   7013
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address
Krebs Stephanie (Reporting) CIK: 0001998150 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39980 | Film No.: 231373274